title: Coffee and its chemopreventive components Kahweol and Cafestol increase the activity of O6-methylguanine-DNA methyltransferase in rat liver--comparison with phase II xenobiotic metabolism.
abstract: A lower rate of colon cancer was observed in consumers of coffee with a high content of the diterpenes Kahweol and Cafestol (K/C). In animal models, K/C have been found to protect against the mutagenic/carcinogenic effects of compounds such as 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), aflatoxin B1, and 7,12-dimethylbenz[a]anthracene. Thus far, such chemoprotection by K/C has been attributed to modifications of xenobiotic metabolism, e.g. enhanced detoxification by UDP-glucuronosyltransferase (UDPGT) and/or glutathione transferase (GST). In the present study, we investigated the potential of several coffee-related treatments (K/C [1:1], Cafestol-alone, Turkish coffee) to modify the expression level of the DNA repair protein O(6)-methylguanine-DNA methyltransferase (MGMT) which is involved in the reversal of the precarcinogenic DNA damage O(6)-alkylguanine induced by alkylating agents. The results show that, in the male F344 rat, K/C and Cafestol increase hepatic MGMT in a dose-dependent manner up to a maximum of 2.6-fold at 0.122% K/C in the feed. Turkish coffee led to enhancements of up to 16%, the more moderate increase being associated with the lower estimated K/C intake through the beverage. In the livers of the rats receiving Turkish coffee, we also found 10-30% increases in several GST-related parameters (overall GST, GST-pi, glutathione, gamma-glutamylcysteine-synthetase) and a two-fold increase in UDPGT activity. Dose-response studies with K/C revealed that MGMT increased in parallel with three of the four GST-related parameters whereas the dose-response curves of UDPGT and of GST-pi activity displayed a steeper slope. Increased expression level of MGMT may extend the antimutagenic/anticarcinogenic potential of coffee components to protection against DNA alkylating agents.
authors.affiliation: Institut für Krebsforschung, University of Vienna, Borschkegasse 8A, Vienna A-1090, Austria. wolfgang.huber@univie.ac.at
authors.forename: Wolfgang W
authors.initials: WW
authors.lastname: Huber
authors.forename: Gerlinde
authors.initials: G
authors.lastname: Scharf
authors.forename: Georg
authors.initials: G
authors.lastname: Nagel
authors.forename: Sonja
authors.initials: S
authors.lastname: Prustomersky
authors.forename: Rolf
authors.initials: R
authors.lastname: Schulte-Hermann
authors.forename: Bernd
authors.initials: B
authors.lastname: Kaina
mesh_terms: D000818:Animals; D003069:Coffee / Q000378:metabolism; D015254:DNA Modification Methylases / Q000187:drug effects*; D004224:Diterpenes / Q000494:pharmacology*; D008099:Liver / Q000187:drug effects* / Q000201:enzymology; D008297:Male; D051381:Rats; D015262:Xenobiotics / Q000378:metabolism
chemical_list: D003069:Coffee; D004224:Diterpenes; D015262:Xenobiotics; C053401:kahweol; C053400:cafestol; D015254:DNA Modification Methylases